Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tevogen Bio Holdings Inc | Ryan Saadi | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 98,901,098 | 98,901,098 | - | - | Common Stock | |
| Tevogen Bio Holdings Inc | Ryan Saadi | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 19,348,954 | 118,250,052 | - | 0 | Common Stock | |
| Tevogen Bio Holdings Inc | Kirti Desai | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 9,696,186 | 9,696,186 | - | - | Common Stock | |
| Tevogen Bio Holdings Inc | Neal Flomenberg | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 5,332,902 | 5,332,902 | - | - | Common Stock | |
| Confluent Inc (Class A) | Matthew Miller | Director | 14 Feb 2024 | 3,637,536 | 7,385,300 | - | - | Class B Common Stock | ||
| Confluent Inc (Class A) | Matthew Miller | Director | Other type of transaction at price $ 0.00 per share. | 14 Feb 2024 | 3,637,536 | 0 | - | 0 | Class A Common Stock | |
| Confluent Inc (Class A) | Matthew Miller | Director | 14 Feb 2024 | 3,637,536 | 3,637,536 | - | 0 | Class A Common Stock | ||
| Geron Corp | Scarlett A. John | Director, CHAIRMAN, PRESIDENT AND CEO | 14 Feb 2024 | 3,000,000 | 3,000,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Kaltura Inc | Ron Yekutiel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 2,746,000 | 11,518,581 | - | - | Common Stock | |
| Maplebear Inc | Jordan Jeffrey D. | Director | Other type of transaction at price $ 0.00 per share. | 14 Feb 2024 | 1,623,788 | 4,871,362 | - | 0 | Common Stock | |
| Geron Corp | J. Andrew Grethlein | EVP, CHIEF OPERATING OFFICER | 14 Feb 2024 | 1,200,000 | 1,200,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Viavi Soln Inc | Oleg Khaykin | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.95 per share. | 14 Feb 2024 | 1,180,257 | 2,329,612 (1%) | 0% | 5.9 | 7,022,529 | Common Stock |
| Viavi Soln Inc | Oleg Khaykin | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 1,180,257 | 0 | - | - | Non Qualified Stock Option | |
| Maplebear Inc | D. Jordan Jeffrey | Director | Other type of transaction at price $ 0.00 per share. | 14 Feb 2024 | 1,178,277 | 3,534,826 | - | 0 | Common Stock | |
| Drilling Tools Intl Corp | Wayne Prejean | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 1,000,000 | 1,000,000 | - | - | Stock Option (Right to Buy) | |
| Tevogen Bio Holdings Inc | Sadiq Khan | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 969,618 | 969,618 | - | - | Common Stock | |
| Tevogen Bio Holdings Inc | Curtis Patton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 969,618 | 969,618 | - | - | Common Stock | |
| Viavi Soln Inc | Oleg Khaykin | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.35 per share. | 14 Feb 2024 | 930,836 | 1,398,776 (0%) | 0% | 9.4 | 8,703,317 | Common Stock |
| Geron Corp | Samuels Alan Scott | EVP & CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 850,000 | 850,000 | - | - | Employee Stock Option (Right to Buy) | |
| Geron Corp | Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 850,000 | 850,000 | - | - | Employee Stock Option (Right to Buy) | |
| Seres Therapeutics Inc | Shaff D. Eric | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 822,580 | 822,580 | - | - | Stock Option (Right to Buy) | |
| Gray Television Inc (Class A) | Howell Robin R. | Director | Grant, award, or other acquisition of securities at price $ 8.26 per share. | 14 Feb 2024 | 787,742 | 3,049,023 (43%) | 11% | 8.3 | 6,506,749 | Class A Common Stock |
| Gray Television Inc (Class A) | Hilton H. Howell | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 8.26 per share. | 14 Feb 2024 | 787,742 | 3,049,023 (43%) | 11% | 8.3 | 6,506,749 | Class A Common Stock |
| Kaltura Inc | Natan Israeli | Chief Customer Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 768,000 | 1,301,452 | - | - | Common Stock | |
| Kaltura Inc | Azaria Eynav | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 768,000 | 1,432,127 | - | - | Common Stock | |
| Geron Corp | Kapur Anil | EVP, CORP STRATEGY & CCO | 14 Feb 2024 | 750,000 | 750,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Geron Corp | Feller Faye | EVP, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 750,000 | 750,000 | - | - | Employee Stock Option (Right to Buy) | |
| Carlyle Grp Inc | Schwartz Harvey M. | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 731,351 | 7,499,397 (2%) | 0% | 0 | Common Stock | |
| Seres Therapeutics Inc | Eric Shaff D. | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 637,500 | 637,500 | - | - | Stock Option (Right to Buy) | |
| Confluent Inc (Class A) | Miller Matthew | Director | Other type of transaction at price $ 0.00 per share. | 14 Feb 2024 | 608,451 | 0 | - | 0 | Class A Common Stock | |
| Confluent Inc (Class A) | Matthew Miller | Director | 14 Feb 2024 | 608,451 | 608,451 | - | 0 | Class A Common Stock | ||
| Confluent Inc (Class A) | Miller Matthew | Director | 14 Feb 2024 | 608,451 | 1,216,897 | - | - | Class B Common Stock | ||
| Tevogen Bio Holdings Inc | Jeffrey Feike | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 581,771 | 581,771 | - | - | Common Stock | |
| Black Diamond Therapeutics Inc | Velleca Mark A. | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 537,000 | 537,000 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | J. Andrew Hirsch | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 465,500 | 465,500 | - | - | Stock Option (Right to Buy) | |
| Definitive Healthcare Corp (Class A) | Krantz Jason | Director, INTERIM CEO, Ten Percent Owner, EXECUTIVE CHAIRMAN | 14 Feb 2024 | 417,752 | 910,877 | - | 0 | Class A Common Stock | ||
| American Fin Grp Inc | Lindner Carl H. | Director, Co-CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2024 | 400,000 | 925,043 (1%) | 0% | 0 | Common Stock | |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 390,187 | 5,763,300 | - | 0 | Common Stock | |
| Drilling Tools Intl Corp | Johnson David | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 380,000 | 380,000 | - | - | Stock Option (Right to Buy) | |
| Gitlab Inc (Class A) | Sijbrandij Sytse | Director, Chief Executive Officer, Ten Percent Owner | 14 Feb 2024 | 380,000 | 380,000 | - | 0 | Class A Common Stock | ||
| Gitlab Inc (Class A) | Sijbrandij Sytse | Director, Chief Executive Officer, Ten Percent Owner | 14 Feb 2024 | 380,000 | 18,242,559 | - | - | Class B Common Stock | ||
| Gray Television Inc (Class A) | LaPlatney Patrick D | Director, President and Co-CEO | Grant, award, or other acquisition of securities at price $ 8.10 per share. | 14 Feb 2024 | 362,222 | 1,034,909 (1%) | 0% | 8.1 | 2,933,998 | Common Stock |
| Talphera Inc | Angotti J. Vincent | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 352,000 | 352,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Paul Berns L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 342,500 | 342,500 | - | - | Stock Option (Right to Buy) | |
| Gitlab Inc (Class A) | Sytse Sijbrandij | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 74.12 per share. | 14 Feb 2024 | 325,674 | 11,933 | - | 74.1 | 24,138,957 | Class A Common Stock |
| Sight Sciences Inc | Bauerlein Alison | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 315,421 | 436,371 | - | 0 | Common Stock | |
| Maplebear Inc | Jeffrey Jordan D. | Director | Sale of securities on an exchange or to another person at price $ 25.85 per share. | 14 Feb 2024 | 303,899 | 161,115 | - | 25.8 | 7,855,789 | Common Stock |
| LeonaBio Inc | Rachel Lenington | COO AND CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Drilling Tools Intl Corp | Michael Domino | President, DTR Divison | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| My Size Inc | Pardo Billy | CPO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 300,000 | 400,000 (19%) | 14% | 0 | Common Stock | |
| My Size Inc | Ronen Luzon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 300,000 | 400,000 (19%) | 14% | 0 | Common Stock | |
| Sable Offshore Corp | Flores J. Caldwell | President | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 14 Feb 2024 | 300,000 | 371,875 | - | 10 | 3,000,000 | Common Stock |
| Seres Therapeutics Inc | J. DesRosier Thomas | Chief Legal Officer and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 287,905 | 287,905 | - | - | Stock Option (Right to Buy) | |
| Seres Therapeutics Inc | A. Arkowitz David | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 287,905 | 287,905 | - | - | Stock Option (Right to Buy) | |
| Seres Therapeutics Inc | Lisa von Moltke | See Remarks | 14 Feb 2024 | 287,905 | 287,905 | - | - | Stock Option (Right to Buy) | ||
| Seres Therapeutics Inc | Ege S. David | See Remarks | 14 Feb 2024 | 287,905 | 287,905 | - | - | Stock Option (Right to Buy) | ||
| Seres Therapeutics Inc | Henn Matthew | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 287,905 | 287,905 | - | - | Stock Option (Right to Buy) | |
| Seres Therapeutics Inc | L. Teresa Young | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 287,905 | 287,905 | - | - | Stock Option (Right to Buy) | |
| LeonaBio Inc | Gengos Andrew | CFO AND CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 280,000 | 280,000 | - | - | Stock Option (Right to Buy) | |
| Gray Television Inc (Class A) | Latek Kevin P. | EVP Chief L & D Officer | Grant, award, or other acquisition of securities at price $ 8.10 per share. | 14 Feb 2024 | 260,000 | 702,033 (0%) | 0% | 8.1 | 2,106,000 | Common Stock |
| Gray Television Inc (Class A) | James Ryan C. | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 8.10 per share. | 14 Feb 2024 | 260,000 | 826,488 (0%) | 0% | 8.1 | 2,106,000 | Common Stock |
| Textron | C. Donnelly Scott | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 238,578 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Textron | Scott C. Donnelly | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 86.41 per share. | 14 Feb 2024 | 238,578 | 685,154 (0%) | 0% | 86.4 | 20,616,432 | Common Stock |
| Textron | Donnelly C. Scott | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.50 per share. | 14 Feb 2024 | 238,578 | 923,732 (0%) | 0% | 34.5 | 8,230,941 | Common Stock |
| Definitive Healthcare Corp (Class A) | Richard D. Booth | CHIEF FINANCIAL OFFICER | 14 Feb 2024 | 232,911 | 514,410 | - | 0 | Class A Common Stock | ||
| Gray Television Inc (Class A) | Breland McNamara Sandra | Executive Vice President, COO | Grant, award, or other acquisition of securities at price $ 8.10 per share. | 14 Feb 2024 | 226,112 | 359,909 (0%) | 0% | 8.1 | 1,831,507 | Common Stock |
| BorgWarner Inc | B. Frederic Lissalde | Director, President and CEO | 14 Feb 2024 | 225,900 | 455,227 (0%) | 0% | 31.1 | 7,021,582 | Common Stock | |
| Black Diamond Therapeutics Inc | Yurasov Sergey | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Sable Offshore Corp | Flores J. Caldwell | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 221,667 | 299,167 | - | - | Warrants | |
| Sable Offshore Corp | Duenner Anthony C. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 221,666 | 271,666 | - | - | Warrants | |
| LeonaBio Inc | Church Kevin | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 220,000 | 220,000 | - | - | Stock Option (Right to Buy) | |
| LeonaBio Inc | Mark Worthington | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 220,000 | 220,000 | - | - | Stock Option (Right to Buy) | |
| Definitive Healthcare Corp (Class A) | Maack Jonathan | PRESIDENT | 14 Feb 2024 | 214,995 | 709,671 | - | 0 | Class A Common Stock | ||
| Seres Therapeutics Inc | von Moltke Lisa | See Remarks | 14 Feb 2024 | 213,750 | 213,750 | - | - | Stock Option (Right to Buy) | ||
| Seres Therapeutics Inc | J. Thomas DesRosier | Chief Legal Officer and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 213,750 | 213,750 | - | - | Stock Option (Right to Buy) | |
| Seres Therapeutics Inc | Arkowitz David A. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 213,750 | 213,750 | - | - | Stock Option (Right to Buy) | |
| Black Diamond Therapeutics Inc | Brent Hatzis-Schoch | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Black Diamond Therapeutics Inc | Elizabeth Buck | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Black Diamond Therapeutics Inc | Ni Fang | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Daljit Singh Aurora | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) | |
| Textron | Scott C. Donnelly | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 86.38 per share. | 14 Feb 2024 | 194,546 | 685,154 (0%) | 0% | 86.4 | 16,805,798 | Common Stock |
| Textron | Scott Donnelly C. | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 194,546 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Textron | Scott C. Donnelly | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.31 per share. | 14 Feb 2024 | 194,546 | 879,700 (0%) | 0% | 44.3 | 8,620,333 | Common Stock |
| Tevogen Bio Holdings Inc | Susan M. Podlogar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 193,923 | 193,923 | - | - | Common Stock | |
| Tevogen Bio Holdings Inc | Ryan Saadi | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 193,923 | 193,923 | - | - | Common Stock | |
| Tevogen Bio Holdings Inc | Keow Lin Goh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 193,923 | 193,923 | - | - | Common Stock | |
| Maplebear Inc | Jordan D. Jeffrey | Director | Sale of securities on an exchange or to another person at price $ 25.85 per share. | 14 Feb 2024 | 193,090 | 102,375 | - | 25.9 | 4,991,377 | Common Stock |
| Alx Oncology Holdings Inc | Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 190,000 | 190,000 | - | - | Employee Stock Option | |
| Seres Therapeutics Inc | S. Ege David | See Remarks | 14 Feb 2024 | 187,500 | 187,500 | - | - | Stock Option (Right to Buy) | ||
| Seres Therapeutics Inc | Henn Matthew | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 187,500 | 187,500 | - | - | Stock Option (Right to Buy) | |
| Seres Therapeutics Inc | L. Young Teresa | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 187,500 | 187,500 | - | - | Stock Option (Right to Buy) | |
| Tutor Perini Corp | Raymond R. Oneglia | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2024 | 182,811 | 0 (0%) | 0% | 0 | Common Stock | |
| Tutor Perini Corp | Raymond R. Oneglia | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2024 | 182,811 | 182,811 (0%) | 0% | 0 | Common Stock | |
| PBF Energy Inc (Class A) | Thomas J. Nimbley | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 181,793 | 806,364 (0%) | 0% | 0 | Class A Common Stock | |
| Ventas | Cafaro A. Debra | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 178,924 | 1,065,978 (0%) | 0% | 0 | Common Stock | |
| Guess Inc | Carlos Alberini | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 172,601 | 1,151,503 (1%) | 0% | 0 | Common Stock | |
| Neumora Therapeutics Inc | L. Berns Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 171,250 | 7,818,166 | - | 0 | Common Stock | |
| Neumora Therapeutics Inc | Joshua Pinto | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Carol Suh | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | M.J. Leonard Reyno | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 165,300 | 165,300 | - | - | Stock Option (Right to Buy) | |
| Maplebear Inc | Jordan Jeffrey D. | Director | Sale of securities on an exchange or to another person at price $ 26.30 per share. | 14 Feb 2024 | 161,115 | 0 | - | 26.3 | 4,237,325 | Common Stock |
| National Retail Properties Inc | Stephen Horn A. | President & CEO | Grant, award, or other acquisition of securities at price $ 39.72 per share. | 14 Feb 2024 | 160,898 | 593,548 (0%) | 0% | 39.7 | 6,390,869 | Common Stock |
| Neumora Therapeutics Inc | Henry Gosebruch O. | Director, President & CEO | 14 Feb 2024 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | ||
| Sight Sciences Inc | Jeremy Hayden B. | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 151,869 | 173,513 | - | 0 | Common Stock | |
| Sight Sciences Inc | Park Sam | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 151,869 | 265,168 | - | 0 | Common Stock | |
| My Size Inc | Kles Or | Chief Financial Officer | 14 Feb 2024 | 150,000 | 174,000 (8%) | 7% | 0 | Common Stock | ||
| My Size Inc | Pardo Billy | CPO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 150,000 | 174,000 (8%) | 7% | 0 | Common Stock | |
| My Size Inc | Ronen Luzon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 150,000 | 174,000 (8%) | 7% | 0 | Common Stock | |
| Uber | Dara Khosrowshahi | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 147,517 | 147,517 | - | - | Restricted Stock Units | |
| Service Corp Intl | Thomas Ryan L. | Director, President, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 141,000 | 141,000 | - | - | Employee Stock Option (right to buy) | |
| Deluxe Corp | C. Barry McCarthy | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 137,845 | 137,845 | - | - | Restricted Stock Unit | |
| Equitable Holdings Inc | Pearson Mark | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 137,319 | 756,944 (0%) | 0% | 0 | Common Stock | |
| United States Cellular Corp | C. Therivel Laurent | Director, President and CEO | 14 Feb 2024 | 136,338 | 136,338 | - | - | Performance Shares Units | ||
| Consolidated Edison | Cawley P. Timothy | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 131,869 | 152,111 (0%) | 0% | - | Common Stock | |
| Consolidated Edison | Timothy P. Cawley | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 131,869 | 0 | - | - | Performance Units | |
| Jefferies Fin Grp Inc | Richard Handler B. | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2024 | 127,801 | 16,595,259 (5%) | 0% | 0 | Common Stock | |
| Jefferies Fin Grp Inc | B. Handler Richard | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2024 | 127,801 | 127,801 (0%) | 0% | 0 | Common Stock | |
| Definitive Healthcare Corp (Class A) | Shamsuddin Kate | CHIEF PRODUCT OFFICER | 14 Feb 2024 | 121,831 | 325,830 | - | 0 | Class A Common Stock | ||
| Aveanna Healthcare Holdings Inc | Windley Rodney D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 119,048 | 0 | - | - | Restricted Stock Units | |
| Aveanna Healthcare Holdings Inc | Rodney Windley D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 119,048 | 2,016,485 | - | - | Common Stock | |
| Kimco Realty - REIT | Jamieson David | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 116,452 | 455,171 (0%) | 0% | 0 | Common Stock | |
| DuPont de Nemours | Edward D. Breen | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 115,202 | 419,054 (0%) | 0% | 0 | Common Stock | |
| Nike | G. Parker Mark | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.76 per share. | 14 Feb 2024 | 110,000 | 1,288,845 (0%) | 0% | 38.8 | 4,263,600 | Class B Common Stock |
| Nike | Parker G. Mark | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 14 Feb 2024 | 110,000 | 1,178,845 (0%) | 0% | 105 | 11,550,000 | Class B Common Stock |
| Nike | G. Parker Mark | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 110,000 | 220,000 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Taylor Morrison Home Corp | Lyon H. William | Director | Sale of securities on an exchange or to another person at price $ 56.68 per share. | 14 Feb 2024 | 109,704 | 2,727,316 (2%) | 0% | 56.7 | 6,218,023 | Common Stock |
| Sight Sciences Inc | Badawi David | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 108,645 | 1,765,904 | - | 0 | Common Stock | |
| Talphera Inc | Asadorian Raffi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 108,000 | 108,000 | - | - | Stock Option (Right to Buy) | |
| Talphera Inc | Palmer Pamela P. | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 108,000 | 108,000 | - | - | Stock Option (Right to Buy) | |
| Seres Therapeutics Inc | D. Shaff Eric | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 106,250 | 106,250 | - | - | Restricted Stock Units | |
| Cooper-Standard Holdings Inc | Edwards Jeffrey S. | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 103,755 | 103,755 | - | - | Performance Stock Units | |
| Citizens Financial Group | Winfield Bruce Van Saun | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 103,712 | 1,162,223 (0%) | 0% | 0 | Common Stock | |
| C4 Therapeutics Inc | Andrew J. Hirsch | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 103,400 | 217,301 | - | 0 | Common Stock | |
| Aveanna Healthcare Holdings Inc | F. Ganzi Victor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 103,175 | 401,403 | - | - | Common Stock | |
| Aveanna Healthcare Holdings Inc | M. Sheldon Retchin | Director | 14 Feb 2024 | 103,175 | 0 | - | - | Restricted Stock Units | ||
| Aveanna Healthcare Holdings Inc | Victor F. Ganzi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 103,175 | 0 | - | - | Restricted Stock Units | |
| Aveanna Healthcare Holdings Inc | Zoretic C. Richard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 103,175 | 0 | - | - | Restricted Stock Units | |
| Aveanna Healthcare Holdings Inc | Schwartz Erica | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 103,175 | 0 | - | - | Restricted Stock Units | |
| Aveanna Healthcare Holdings Inc | Richard C. Zoretic | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 103,175 | 195,795 | - | - | Common Stock | |
| Aveanna Healthcare Holdings Inc | Sheldon Retchin M. | Director | 14 Feb 2024 | 103,175 | 242,543 | - | - | Common Stock | ||
| Aveanna Healthcare Holdings Inc | Erica Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 103,175 | 175,295 | - | - | Common Stock | |
| Maplebear Inc | Jeffrey Jordan D. | Director | Sale of securities on an exchange or to another person at price $ 26.30 per share. | 14 Feb 2024 | 102,375 | 0 | - | 26.3 | 2,692,463 | Common Stock |
| Fifth Third Bancorp | Spence N. Timothy | Director, Chair, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 101,957 | 101,957 | - | - | Stock Appreciation Rights | |
| American Fin Grp Inc | David Lawrence Thompson | President of Subsidiary | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2024 | 100,000 | 489,948 (0%) | 0% | 0 | Common Stock | |
| Black Diamond Therapeutics Inc | Jones Erika | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Robert Lenz | Head of R&D | 14 Feb 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | ||
| Neumora Therapeutics Inc | Daljit Singh Aurora | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 97,500 | 212,203 | - | 0 | Common Stock | |
| MACOM Tech Soln Holdings Inc | Susan Ocampo | Director, Ten Percent Owner | 14 Feb 2024 | 97,103 | 7,148,565 (10%) | 0% | 85.5 | 8,301,335 | Common Stock | |
| Tevogen Bio Holdings Inc | Victor Sordillo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 96,962 | 96,962 | - | - | Common Stock | |
| Alx Oncology Holdings Inc | Randolph Sophia | Director, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 95,000 | 95,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 14 Feb 2024 | 95,000 | 95,000 | - | - | Employee Stock Option (right to buy) | ||
| BP PLC (ADR) | Anne Katherine Thomson | Executive Director,Chief Financial Officer | 14 Feb 2024 | 93,377 | 162,551 (0%) | 0% | 0 | Ords 0.25p | ||
| PBF Energy Inc (Class A) | Nimbley Thomas J. | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.24 per share. | 14 Feb 2024 | 92,987 | 713,377 (0%) | 0% | 52.2 | 4,857,641 | Class A Common Stock |
| Quest Diagnostics | James E. Davis | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 92,779 | 92,779 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Cooper-Standard Holdings Inc | Jeffrey Edwards S. | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 88,837 | 88,837 | - | - | Restricted Stock Units | |
| Talphera Inc | Badri Dasu | Chief Engineering Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 88,000 | 88,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc | Joshua Pinto | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 85,000 | 323,965 | - | 0 | Common Stock | |
| Neumora Therapeutics Inc | Suh Carol | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 85,000 | 374,674 | - | 0 | Common Stock | |
| Ares Management Corp (Class A) | R. DeVeer Kipp | Director, Head of Credit Group | Sale of securities on an exchange or to another person at price $ 136.47 per share. | 14 Feb 2024 | 82,796 | 1,245,729 (1%) | 0% | 136.5 | 11,299,170 | Class A Common Stock |
| ANI Pharma Inc | Nikhil Lalwani | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 80,530 | 430,274 (3%) | 0% | 0 | Common Stock | |
| Alx Oncology Holdings Inc | Garcia Peter S. | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 80,000 | 80,000 | - | - | Employee Stock Option (right to buy) | |
| Neumora Therapeutics Inc | Gosebruch Henry O. | Director, President & CEO | 14 Feb 2024 | 80,000 | 462,345 | - | 0 | Common Stock | ||
| Wabash National Corp | Brent Yeagy L. | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 79,485 | 355,272 (0%) | 0% | 0 | Common Stock | |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.61 per share. | 14 Feb 2024 | 79,261 | 986,717 (0%) | 0% | 45.6 | 3,615,094 | Common Stock |
| PBF Energy Inc (Class A) | Lucey Matthew C. | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 75,895 | 319,717 (0%) | 0% | 0 | Class A Common Stock | |
| Kimco Realty - REIT | David Jamieson | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.81 per share. | 14 Feb 2024 | 72,303 | 382,868 (0%) | 0% | 19.8 | 1,432,322 | Common Stock |
| Cooper-Standard Holdings Inc | Edwards S. Jeffrey | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 70,240 | 70,240 | - | - | Performance Stock Units | |
| BP PLC (ADR) | Katherine Anne Thomson | Executive Director,Chief Financial Officer | 14 Feb 2024 | 69,169 | 69,174 (0%) | 0% | 0 | Ords 0.25p | ||
| Textron | T. Connor Frank | Executive Vice President & CFO | 14 Feb 2024 | 68,718 | 220,467 (0%) | 0% | 34.5 | 2,370,771 | Common Stock | |
| Textron | Frank Connor T. | Executive Vice President & CFO | 14 Feb 2024 | 68,718 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Textron | T. Connor Frank | Executive Vice President & CFO | 14 Feb 2024 | 68,718 | 151,749 (0%) | 0% | 86.4 | 5,938,108 | Common Stock | |
| Fifth Third Bancorp | Timothy N. Spence | Director, Chair, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 66,705 | 360,565 (0%) | 0% | 0 | Common Stock | |
| Uber | Nikki Krishnamurthy | SVP and Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 66,065 | 66,065 | - | - | Restricted Stock Units | |
| Consolidated Edison | P. Cawley Timothy | Director, Chairman, President & CEO | Sale or transfer of securities back to the company at price $ 86.67 per share. | 14 Feb 2024 | 65,935 | 86,176 (0%) | 0% | 86.7 | 5,714,586 | Common Stock |
| Altice USA Inc (Class A) | Svider Raymond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 64,935 | 169,316 (0%) | 0% | - | Class A common stock | |
| Altice USA Inc (Class A) | Mullen Mark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 64,935 | 110,316 (0%) | 0% | - | Class A common stock | |
| Altice USA Inc (Class A) | Schnabel C. Susan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 64,935 | 130,316 (0%) | 0% | - | Class A common stock | |
| National Retail Properties Inc | B. Kevin Habicht | EVP, Chief Financial Officer | 14 Feb 2024 | 64,576 | 335,029 (0%) | 0% | 39.7 | 2,564,959 | Common Stock | |
| Consolidated Edison | Cawley P. Timothy | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 63,400 | 0 | - | - | Performance Units | |
| OneMain Holdings Inc | Shulman Douglas H. | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 61,138 | 515,557 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| PBF Energy Inc (Class A) | O'Connor Thomas L. | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 60,772 | 191,423 (0%) | 0% | 0 | Class A Common Stock | |
| PBF Energy Inc (Class A) | T. Paul Davis | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 60,772 | 142,063 (0%) | 0% | 0 | Class A Common Stock | |
| PBF Energy Inc (Class A) | Trecia Canty M. | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 60,772 | 150,359 (0%) | 0% | 0 | Class A Common Stock | |
| Pegasystems Inc | Trefler Alan | C.E.O. & Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 60,409 | 60,409 | - | - | Stock Options | |
| Alx Oncology Holdings Inc | Lettmann Jason | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 60,000 | 167,220 | - | 0 | Common Stock | |
| Andersons Inc | Bowe E. Patrick | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 59,542 | 0 | - | - | PERFORMANCE SHARE UNIT (EPS) (2024) | |
| Andersons Inc | Patrick Bowe E. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 59,542 | 0 | - | - | PERFORMANCE SHARE UNIT (TSR) (2024) | |
| Andersons Inc | E. Patrick Bowe | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 59,542 | 108,459 (0%) | 0% | 0 | Common Stock | |
| Andersons Inc | Patrick Bowe E. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 59,542 | 168,001 (0%) | 0% | 0 | Common Stock | |
| Talphera Inc | J. Angotti Vincent | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 58,667 | 153,429 (0%) | 0% | 0 | Common Stock | |
| Nike | Parker G. Mark | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 14 Feb 2024 | 58,378 | 1,178,845 (0%) | 0% | 105 | 6,129,690 | Class B Common Stock |
| KalVista Pharma Inc | Crockett Thomas Andrew | Director, CEO | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 14 Feb 2024 | 58,356 | 181,676 (1%) | 0% | 15.0 | 875,883 | Common Stock |
| Moderna | Bancel Stephane | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 56,736 | 5,486,575 (1%) | 0% | 0 | Common Stock | |
| Textron | Connor Frank T. | Executive Vice President & CFO | 14 Feb 2024 | 56,705 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Textron | Connor Frank T. | Executive Vice President & CFO | 14 Feb 2024 | 56,705 | 208,454 (0%) | 0% | 44.3 | 2,512,599 | Common Stock | |
| Textron | Frank Connor T. | Executive Vice President & CFO | 14 Feb 2024 | 56,705 | 151,749 (0%) | 0% | 86.4 | 4,898,688 | Common Stock | |
| Elme Communities | T. McDermott Paul | Director, President, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 56,429 | 590,199 (0%) | 0% | 0 | Common Stock | |
| Andersons Inc | Bowe E. Patrick | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.76 per share. | 14 Feb 2024 | 54,909 | 118,111 (0%) | 0% | 52.8 | 2,896,999 | Common Stock |
| DuPont de Nemours | Edward Breen D. | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.16 per share. | 14 Feb 2024 | 54,088 | 364,966 (0%) | 0% | 67.2 | 3,632,550 | Common Stock |
| ANI Pharma Inc | Nikhil Lalwani | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 53,686 | 483,960 (4%) | 0% | 0 | Common Stock | |
| United States Cellular Corp | Irizarry S. Michael | EVP-CTO | 14 Feb 2024 | 52,042 | 52,042 | - | - | Performance Share Units | ||
| HNI Corp | D. Jeffrey Lorenger | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 51,862 | 346,755 (0%) | 0% | 0 | Common Stock | |
| SoFi Tech Inc | Chad M. Borton | President - SoFi Bank | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 51,246 | 291,218 | - | - | Common Stock | |
| SoFi Tech Inc | Borton Chad M. | President - SoFi Bank | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 51,246 | 1,159,395 | - | - | Restricted Stock Unit | |
| Neumora Therapeutics Inc | Lenz Robert | Head of R&D | 14 Feb 2024 | 50,000 | 402,941 | - | 0 | Common Stock | ||
| Uber | Jill Hazelbaker | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 48,679 | 48,679 | - | - | Restricted Stock Units | |
| Smurfit WestRock | Anthony P J Smurfit | Executive Director,President and Chief Executive Officer | 14 Feb 2024 | 48,236 | 1,543,878 (0%) | 0% | - | Ords 0.00p | ||
| Deluxe Corp | Barry C. McCarthy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 46,888 | 179,491 (0%) | 0% | 0 | Common Stock | |
| Deluxe Corp | C. Barry McCarthy | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 46,888 | 93,777 | - | - | Restricted Stock Unit | |
| Rocket Pharmaceuticals Inc | Shah Gaurav | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 46,828 | 575,034 (1%) | 0% | 0 | Common Stock | |
| Ares Management Corp (Class A) | Kipp DeVeer R. | Director, Head of Credit Group | Sale of securities on an exchange or to another person at price $ 135.02 per share. | 14 Feb 2024 | 45,958 | 1,151,355 (0%) | 0% | 135.0 | 6,205,249 | Class A Common Stock |
| Northrop Grumman | Kathy J. Warden | Director, Chair, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 45,832 | 73,212 | - | - | Restricted Performance Stock Rights | |
| Northrop Grumman | Warden Kathy J. | Director, Chair, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 45,832 | 207,063 (0%) | 0% | 0 | Common Stock | |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 14 Feb 2024 | 44,770 | 998,786 | - | - | Class B Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 14 Feb 2024 | 44,770 | 682,770 (0%) | 0% | 0 | Class A Common Stock | ||
| Gitlab Inc (Class A) | Sytse Sijbrandij | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 73.34 per share. | 14 Feb 2024 | 42,393 | 337,607 | - | 73.3 | 3,109,103 | Class A Common Stock |
| Acrivon Therapeutics Inc | Blume-Jensen Peter | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.40 per share. | 14 Feb 2024 | 41,861 | 2,616,812 | - | 3.4 | 142,327 | Common Stock |
| Incyte | Hoppenot Herve | Director, Chairman / CEO, President | 14 Feb 2024 | 41,577 | 502,333 (0%) | 0% | 0 | Common Stock | ||
| Neumora Therapeutics Inc | Lee Michael Milligan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 41,250 | 41,250 | - | - | Stock Option (Right to Buy) | |
| United States Cellular Corp | Chambers Douglas W. | EVP-CFO & Treasurer | 14 Feb 2024 | 41,132 | 41,132 | - | - | Performance Shares Units | ||
| Ares Management Corp (Class A) | R. Kipp DeVeer | Director, Head of Credit Group | Sale of securities on an exchange or to another person at price $ 135.28 per share. | 14 Feb 2024 | 41,073 | 1,204,656 (1%) | 0% | 135.3 | 5,556,355 | Class A Common Stock |
| Ventas | Probst Robert F. | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 40,863 | 213,003 (0%) | 0% | 0 | Common Stock | |
| KalVista Pharma Inc | L. Palleiko Benjamin | CFO, CBO | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 14 Feb 2024 | 40,855 | 159,088 (0%) | 0% | 15.0 | 613,205 | Common Stock |
| Pixelworks Inc | Todd Debonis A. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 40,000 | 1,621,477 (4%) | 0% | - | Common Stock | |
| TG Therapeutics Inc | A. Sean Power | CFO | 14 Feb 2024 | 40,000 | 641,969 (0%) | 0% | 0 | Common Stock | ||
| KalVista Pharma Inc | Christopher M. Yea | CHIEF DEVELOPMENT OFFICER | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 14 Feb 2024 | 39,886 | 66,160 (0%) | 0% | 15.0 | 598,661 | Common Stock |
| Citizens Financial Group | Donald H. McCree | Head of Commercial Banking | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 39,494 | 181,446 (0%) | 0% | 0 | Common Stock | |
| Plymouth Industrial Reit Inc | Jeffrey E. Witherell | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 39,398 | 250,248 (1%) | 0% | 0 | Common Stock | |
| Citizens Financial Group | Woods F. John | Chief Financial Officer | 14 Feb 2024 | 38,944 | 248,642 (0%) | 0% | 0 | Common Stock | ||
| Rocket Pharmaceuticals Inc | Gaurav Shah | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 38,849 | 77,468 | - | - | Restricted Stock Units | |
| PBF Energy Inc (Class A) | Matthew Lucey C. | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.24 per share. | 14 Feb 2024 | 38,820 | 280,897 (0%) | 0% | 52.2 | 2,027,957 | Class A Common Stock |
| Fifth Third Bancorp | Jamie Leonard C. | EVP & Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 38,620 | 38,620 | - | - | Stock Appreciation Rights | |
| Merck & Company | Litchfield Caroline | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.08 per share. | 14 Feb 2024 | 38,291 | 89,199 (0%) | 0% | 58.1 | 2,223,941 | Common Stock |
| Merck & Company | Litchfield Caroline | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 38,291 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Company | Caroline Litchfield | EVP & CFO | Sale of securities on an exchange or to another person at price $ 125.50 per share. | 14 Feb 2024 | 38,291 | 50,908 (0%) | 0% | 125.5 | 4,805,521 | Common Stock |
| Consolidated Edison | N. Hoglund Robert | SVP and CFO | Sale or transfer of securities back to the company at price $ 86.67 per share. | 14 Feb 2024 | 38,211 | 44,869 (0%) | 0% | 86.7 | 3,311,747 | Common Stock |
| Consolidated Edison | Matthew Ketschke | President, CECONY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 38,211 | 41,218 (0%) | 0% | 0 | Common Stock | |
| Consolidated Edison | Ketschke Matthew | President, CECONY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 38,211 | 0 | - | - | Performance Units | |
| Consolidated Edison | Hoglund N. Robert | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 38,211 | 83,080 (0%) | 0% | - | Common Stock | |
| Consolidated Edison | Hoglund Robert N. | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 38,211 | 0 | - | - | Performance Units | |
| Keycorp | Gormley Christopher L. | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.92 per share. | 14 Feb 2024 | 38,022 | 872,199 (0%) | 0% | 12.9 | 491,244 | Common Shares |
| Keycorp | Christopher L. Gormley | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 38,022 | 0 | - | - | Option to Buy | |
| Northrop Grumman | Kathy J. Warden | Director, Chair, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 37,636 | 119,044 | - | - | Restricted Performance Stock Rights | |
| Murphy USA Inc | Andrew R. Clyde | Director, President & CEO | 14 Feb 2024 | 37,634 | 216,029 (0%) | 0% | 0 | Common Stock | ||
| Elme Communities | McDermott T. Paul | Director, President, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 37,015 | 627,214 (0%) | 0% | 0 | Common Stock | |
| C4 Therapeutics Inc | Reyno Leonard M.J. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 36,700 | 98,000 | - | 0 | Common Stock | |
| Cloudflare Inc (Class A) | Carl Ledbetter | Director | Sale of securities on an exchange or to another person at price $ 99.90 per share. | 14 Feb 2024 | 36,644 | 1,370,642 (1%) | 0% | 99.9 | 3,660,897 | Class A Common Stock |
| Definitive Healthcare Corp (Class A) | Lazorchak Carrie | CHIEF REVENUE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 35,833 | 421,528 | - | 0 | Class A Common Stock | |
| Seres Therapeutics Inc | J. Thomas DesRosier | Chief Legal Officer and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 35,625 | 35,625 | - | - | Restricted Stock Units | |
| Seres Therapeutics Inc | von Moltke Lisa | See Remarks | 14 Feb 2024 | 35,625 | 35,625 | - | - | Restricted Stock Units | ||
| Seres Therapeutics Inc | David A. Arkowitz | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 35,625 | 35,625 | - | - | Restricted Stock Units | |
| Service Corp Intl | Ryan Thomas L. | Director, President, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 35,600 | 486,300 (0%) | 0% | 0 | Common Stock | |
| Service Corp Intl | Eric D. Tanzberger | Sr. VP, and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 35,300 | 35,300 | - | - | Employee stock option (right to buy) | |
| Alx Oncology Holdings Inc | Pinto Shelly | SVP, FINANCE AND CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 35,000 | 35,000 | - | - | Employee Stock Option (right to buy) | |
| BlackBerry Ltd | G. Philip Brace | Director | Purchase of securities on an exchange or from another person at price $ 2.79 per share. | 14 Feb 2024 | 35,000 | 35,000 (0%) | 0% | 2.8 | 97,650 | Common Shares |
| RTX | G. Shane Eddy | President, P&W | Sale of securities on an exchange or to another person at price $ 91.19 per share. | 14 Feb 2024 | 35,000 | 6,741 (0%) | 0% | 91.2 | 3,191,752 | Common Stock |
| United States Cellular Corp | R. Kevin Lowell | EVP, Chief People Officer | 14 Feb 2024 | 34,937 | 34,937 | - | - | Performance Shares Units | ||
| Uber | West Tony | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 34,772 | 34,772 | - | - | Restricted Stock Units | |
| Ares Management Corp (Class A) | DeVeer Kipp R. | Director, Head of Credit Group | Sale of securities on an exchange or to another person at price $ 135.55 per share. | 14 Feb 2024 | 34,679 | 1,116,676 (0%) | 0% | 135.5 | 4,700,738 | Class A Common Stock |
| National Retail Properties Inc | A. Horn Stephen | President & CEO | Grant, award, or other acquisition of securities at price $ 39.72 per share. | 14 Feb 2024 | 34,478 | 432,650 (0%) | 0% | 39.7 | 1,369,466 | Common Stock |
| Kaltura Inc | Yaron Garmazi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 34,000 | 1,057,320 | - | - | Common Stock | |
| Service Corp Intl | Waring Sumner J. | Sr.VP& Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 33,600 | 33,600 | - | - | Employee Stock Option (right to buy) | |
| Fifth Third Bancorp | Timothy N. Spence | Director, Chair, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 33,552 | 387,857 (0%) | 0% | 0 | Common Stock | |
| Energy Services of America Corp | L. Williams Joseph | Director | Sale of securities on an exchange or to another person at price $ 7.94 per share. | 14 Feb 2024 | 33,200 | 100,250 | - | 7.9 | 263,608 | Common stock |
| Smurfit WestRock | Anthony P J Smurfit | Executive Director,President and Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 37.26 per share. | 14 Feb 2024 | 32,886 | 1,493,878 (0%) | 0% | 37.3 | 1,225,332 | Ords 0.00p |
| KB Home | Z. Praw Albert | EVP, Real Estate & Bus. Dev. | Sale of securities on an exchange or to another person at price $ 60.76 per share. | 14 Feb 2024 | 32,528 | 135,512 (0%) | 0% | 60.8 | 1,976,401 | Common Stock |
| Diodes Inc | Lu Keh-Shew | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 32,000 | 166,268 (0%) | 0% | 0 | Diodes Incorporated Common Stock | |
| Equitable Holdings Inc | Nicholas B. Lane | (See Remarks) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 31,963 | 176,095 (0%) | 0% | 0 | Common Stock | |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 14 Feb 2024 | 31,493 | 31,493 (0%) | 0% | 0 | Class A Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 14 Feb 2024 | 31,493 | 295,759,054 | - | - | Class B Common Stock | ||
| DuPont de Nemours | D. Koch Lori | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 31,419 | 97,326 (0%) | 0% | 0 | Common Stock | |
| Equitable Holdings Inc | Raju Robin M. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 31,371 | 128,796 (0%) | 0% | 0 | Common Stock | |
| Pixelworks Inc | A. Todd Debonis | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.56 per share. | 14 Feb 2024 | 31,341 | 1,590,136 (4%) | 0% | 2.6 | 80,083 | Common Stock |
| Seres Therapeutics Inc | Eric Shaff D. | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 31,250 | 146,870 (0%) | 0% | - | Common Stock | |
| Seres Therapeutics Inc | S. David Ege | See Remarks | 14 Feb 2024 | 31,250 | 31,250 | - | - | Restricted Stock Units | ||
| Seres Therapeutics Inc | Matthew Henn | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 31,250 | 31,250 | - | - | Restricted Stock Units | |
| Seres Therapeutics Inc | L. Young Teresa | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 31,250 | 31,250 | - | - | Restricted Stock Units | |
| Seres Therapeutics Inc | Shaff D. Eric | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 31,250 | 93,750 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Kevin Conroy T. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 31,133 | 1,239,148 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | T. Kevin Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 31,133 | 0 | - | - | Restricted Stock Units | |
| PBF Energy Inc (Class A) | Paul Davis T. | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.24 per share. | 14 Feb 2024 | 31,085 | 110,978 (0%) | 0% | 52.2 | 1,623,880 | Class A Common Stock |
| PBF Energy Inc (Class A) | M. Trecia Canty | SVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.24 per share. | 14 Feb 2024 | 31,085 | 119,274 (0%) | 0% | 52.2 | 1,623,880 | Class A Common Stock |
| PBF Energy Inc (Class A) | Thomas L. O'Connor | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.24 per share. | 14 Feb 2024 | 31,085 | 160,338 (0%) | 0% | 52.2 | 1,623,880 | Class A Common Stock |
| Fifth Third Bancorp | Shaffer Robert P. | EVP and Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 30,896 | 30,896 | - | - | Stock Appreciation Rights | |
| Fifth Third Bancorp | Kevin Lavender P. | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 30,896 | 30,896 | - | - | Stock Appreciation Rights | |
| Deluxe Corp | Tracey Engelhardt G. | SVP, Division President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 30,075 | 30,075 | - | - | Restricted Stock Unit | |
| Alx Oncology Holdings Inc | Jaume Pons | Director, PRESIDENT & CSO | 14 Feb 2024 | 30,000 | 648,359 | - | 0 | Common Stock | ||
| Alx Oncology Holdings Inc | Sophia Randolph | Director, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 30,000 | 342,349 | - | 0 | Common Stock | |
| General Electric Co. | Michael Holston J. | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 30,000 | 4,733 | - | - | Employee Stock Option (right to buy) | |
| General Electric Co. | Holston Michael J. | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.42 per share. | 14 Feb 2024 | 30,000 | 78,339 (0%) | 0% | 75.4 | 2,262,600 | Common Stock |
| Matador Resources Co | Wm. Foran Joseph | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 30,000 | 30,000 | - | - | Phantom Units | |
| Equitable Holdings Inc | J. Hurd Jeffrey | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 29,595 | 175,300 (0%) | 0% | 0 | Common Stock | |
| CTO Realty Growth Inc - Ordinary Shares- New | P. John Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 29,525 | 600,042 (12%) | 0% | 0 | Common Stock | |
| Deluxe Corp | Zint William C | SVP, Chief Financial Offier | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 28,822 | 28,822 | - | - | Restricted Stock Unit | |
| DuPont de Nemours | Jon D. Kemp | President, Electronics & Indus | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 28,800 | 110,660 (0%) | 0% | 0 | Common Stock | |
| KalVista Pharma Inc | Edward Feener P. | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 14 Feb 2024 | 28,171 | 71,657 (0%) | 0% | 15.0 | 422,827 | Common Stock |
| Maplebear Inc | D. Jeffrey Jordan | Director | Other type of transaction at price $ 0.00 per share. | 14 Feb 2024 | 28,158 | 28,158 | - | 0 | Common Stock | |
| NAPCO Security Tech Inc | Richard L. Soloway | Director, President, CEO and Secretary, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.12 per share. | 14 Feb 2024 | 28,000 | 3,706,010 (20%) | 0% | 45.1 | 1,263,360 | Common Stock |
| C4 Therapeutics Inc | Mark Mossler | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 27,430 | 27,430 | - | - | Stock Option (Right to Buy) | |
| AMD | Lisa T. Su | Director, Chair, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2024 | 27,280 | 3,320,360 (0%) | 0% | 0 | Common Stock | |
| Consolidated Edison | P. Cawley Timothy | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 27,200 | 0 | - | - | Time - Based Restricted Stock Units | |
| Fifth Third Bancorp | Jamie Leonard C. | EVP & Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 26,841 | 209,180 (0%) | 0% | 0 | Common Stock | |
| Moderna | Bancel Stephane | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 88.88 per share. | 14 Feb 2024 | 26,351 | 5,460,224 (1%) | 0% | 88.9 | 2,342,098 | Common Stock |
| Verizon Communincations | Vestberg Hans Erik | Director, Chairman and CEO | 14 Feb 2024 | 26,247 | 215,014 (0%) | 0% | - | Common Stock | ||
| Rocket Pharmaceuticals Inc | Patel Kinnari | See Remarks | 14 Feb 2024 | 26,189 | 245,478 (0%) | 0% | 0 | Common Stock | ||
| Pixelworks Inc | Debonis Todd A. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 26,000 | 1,581,477 (4%) | 0% | - | Common Stock | |
| Fifth Third Bancorp | Leonard C. Jamie | EVP & Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 25,267 | 184,224 (0%) | 0% | 0 | Common Stock | |
| Diodes Inc | Keh-Shew Lu | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.16 per share. | 14 Feb 2024 | 25,184 | 141,084 (0%) | 0% | 68.2 | 1,716,541 | Diodes Incorporated Common Stock |
| Pixelworks Inc | Todd Debonis A. | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.56 per share. | 14 Feb 2024 | 25,071 | 1,565,065 (4%) | 0% | 2.6 | 64,061 | Common Stock |
| BP PLC (ADR) | Anne Katherine Thomson | Executive Director,Chief Financial Officer | 14 Feb 2024 | 25,060 | 187,611 (0%) | 0% | 0 | Ords 0.25p | ||
| Alx Oncology Holdings Inc | Garcia S. Peter | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 25,000 | 110,348 | - | 0 | Common Stock | |
| Coursera Inc | Hahn Kenneth R. | SVP, Chief Financial Officer | 14 Feb 2024 | 25,000 | 532,715 | - | 17.0 | 425,245 | Common Stock | |
| Beacon Fin Corp | A. Michael Zaitzeff | Director | Sale of securities on an exchange or to another person at price $ 22.40 per share. | 14 Feb 2024 | 24,910 | 38,855 (0%) | 0% | 22.4 | 558,046 | Common Stock |
| BJ`s Restaurant Inc | Gregory Trojan A. | Director | 14 Feb 2024 | 24,871 | 152,339 (0%) | 0% | 34.7 | 863,521 | Common Stock | |
| Coursera Inc | Kenneth Hahn R. | SVP, Chief Financial Officer | 14 Feb 2024 | 24,841 | 507,874 | - | 17.0 | 423,291 | Common Stock | |
| Prestige Consumer Healthcare Inc | Sacco Christine | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 68.41 per share. | 14 Feb 2024 | 24,788 | 21,738 (0%) | 0% | 68.4 | 1,695,747 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthcare Inc | Christine Sacco | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.46 per share. | 14 Feb 2024 | 24,788 | 46,526 (0%) | 0% | 29.5 | 730,254 | Common Stock, par value $0.01 per share |
| Prestige Consumer Healthcare Inc | Sacco Christine | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 24,788 | 0 | - | - | Employee Stock Options (rights to buy) | |
| Fifth Third Bancorp | P. Shaffer Robert | EVP and Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 24,605 | 138,326 (0%) | 0% | 0 | Common Stock | |
| Fifth Third Bancorp | P. Kevin Lavender | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 24,605 | 107,676 (0%) | 0% | 0 | Common Stock | |
| Beacon Fin Corp | A. Zaitzeff Michael | Director | Sale of securities on an exchange or to another person at price $ 22.72 per share. | 14 Feb 2024 | 24,182 | 63,765 (0%) | 0% | 22.7 | 549,495 | Common Stock |
| Consolidated Edison | Sanchez Robert | President & CEO, O&R | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 24,065 | 0 | - | - | Performance Units | |
| Consolidated Edison | Robert Sanchez | President & CEO, O&R | Sale or transfer of securities back to the company at price $ 86.67 per share. | 14 Feb 2024 | 24,065 | 13,472 (0%) | 0% | 86.7 | 2,085,714 | Common Stock |
| Consolidated Edison | Sanchez Robert | President & CEO, O&R | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 24,065 | 37,537 (0%) | 0% | - | Common Stock | |
| Xylem | Rodney O. Aulick | SVP & President, WSS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.50 per share. | 14 Feb 2024 | 23,870 | 104,365 (0%) | 0% | 43.5 | 1,038,345 | Common Stock |
| Xylem | Rodney O. Aulick | SVP & President, WSS | Sale of securities on an exchange or to another person at price $ 122.55 per share. | 14 Feb 2024 | 23,870 | 80,495 (0%) | 0% | 122.5 | 2,925,159 | Common Stock |
| Xylem | Rodney O. Aulick | SVP & President, WSS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 23,870 | 23,870 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Deluxe Corp | Jeffrey L. Cotter | SVP, CAO and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 23,810 | 23,810 | - | - | Restricted Stock Unit | |
| Ventas | Bulgarelli Peter J. | Pres&CEO-LHS/EVP Office-Ventas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 23,564 | 122,231 (0%) | 0% | 0 | Common Stock | |
| Ventas | Justin J. Hutchens | EVP Senior Housing and CIO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 23,528 | 139,154 (0%) | 0% | 0 | Common Stock | |
| Smurfit WestRock | Ken Bowles | Executive Director,Executive Vice President and Group Chief Financial Officer | 14 Feb 2024 | 23,269 | 133,535 (0%) | 0% | - | Ords 0.00p | ||
| Wabash National Corp | T. Smith Dustin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 23,183 | 84,848 (0%) | 0% | 0 | Common Stock | |
| Wabash National Corp | Pettit Michael N. | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 23,183 | 105,167 (0%) | 0% | 0 | Common Stock | |
| DoorDash | Tia Sherringham | GENERAL COUNSEL AND SECRETARY | Sale of securities on an exchange or to another person at price $ 120.08 per share. | 14 Feb 2024 | 23,125 | 194,135 | - | 120.1 | 2,776,781 | Class A Common Stock |
| Deluxe Corp | McCarthy Barry C. | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.81 per share. | 14 Feb 2024 | 23,069 | 156,422 (0%) | 0% | 20.8 | 480,066 | Common Stock |
| Quest Diagnostics | Samad A. Sam | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 22,835 | 22,835 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Cooper-Standard Holdings Inc | Jonathan P. Banas | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 22,794 | 22,794 | - | - | Restricted Stock Units | |
| Moderna | Stephen Hoge | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 22,694 | 1,538,975 (0%) | 0% | 0 | Common Stock | |
| Exponent Inc | Corrigan Ford Catherine | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 22,681 | 22,681 | - | - | Non-Qualified Stock Option (right to buy) | |
| Service Corp Intl | Steven Tidwell A. | Sr.V.P. Sales & Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 22,600 | 22,600 | - | - | Employee Stock Option (right to buy) | |
| Deluxe Corp | Yogaraj Jeyaprakasam | Chief Tech. & Digital Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 22,556 | 22,556 | - | - | Restricted Stock Unit | |
| Cooper-Standard Holdings Inc | Banas P. Jonathan | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 22,526 | 22,526 | - | - | Performance Stock Units | |
| Quest Diagnostics | E. James Davis | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 22,251 | 124,885 (0%) | 0% | 0 | Common Stock | |
| Rocket Pharmaceuticals Inc | Kinnari Patel | See Remarks | 14 Feb 2024 | 22,199 | 44,268 | - | - | Restricted Stock Units | ||
| Elme Communities | Tiffany Butcher Michelle | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 22,093 | 41,584 (0%) | 0% | 0 | Common Stock | |
| Smurfit WestRock | Ken Bowles | Executive Director,Executive Vice President and Group Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 37.39 per share. | 14 Feb 2024 | 22,077 | 111,458 (0%) | 0% | 37.4 | 825,459 | Ords 0.00p |
| General Electric Co. | J. Michael Holston | Senior Vice President | Sale of securities on an exchange or to another person at price $ 144.87 per share. | 14 Feb 2024 | 22,055 | 56,284 (0%) | 0% | 144.9 | 3,195,108 | Common Stock |
| Pixelworks Inc | A. Todd Debonis | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 22,000 | 1,555,477 (4%) | 0% | - | Common Stock | |
| Plymouth Industrial Reit Inc | Anthony Saladino | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 21,796 | 58,168 (0%) | 0% | 0 | Common Stock | |
| ANI Pharma Inc | Carey Stephen P. | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 21,474 | 177,313 (1%) | 0% | 0 | Common Stock | |
| Consolidated Edison | Deneen L. Donnley | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 21,463 | 0 | - | - | Performance Units | |
| Consolidated Edison | L. Donnley Deneen | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 21,463 | 29,823 (0%) | 0% | - | Common Stock | |
| Idexx Laboratories | Jonathan Mazelsky J. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 21,335 | 21,335 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| Tractor Supply | Mills D. Robert | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 231.51 per share. | 14 Feb 2024 | 21,104 | 49,397 (0%) | 0% | 231.5 | 4,885,787 | Common stock |
| Taylor Morrison Home Corp | Lyon H. William | Director | Sale of securities on an exchange or to another person at price $ 56.01 per share. | 14 Feb 2024 | 20,896 | 2,837,020 (2%) | 0% | 56.0 | 1,170,385 | Common Stock |
| Neumora Therapeutics Inc | Michael Milligan Lee | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 20,625 | 24,448 | - | 0 | Common Stock | |
| Beacon Fin Corp | Michael A. Zaitzeff | Director | Sale of securities on an exchange or to another person at price $ 22.02 per share. | 14 Feb 2024 | 20,500 | 87,947 (0%) | 0% | 22.0 | 451,416 | Common Stock |
| Cooper-Standard Holdings Inc | Patrick R. Clark | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 20,478 | 20,478 | - | - | Performance Stock Units | |
| Northrop Grumman | Warden J. Kathy | Director, Chair, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.37 per share. | 14 Feb 2024 | 20,335 | 186,728 (0%) | 0% | 446.4 | 9,076,934 | Common Stock |
| Fifth Third Bancorp | Kevin Lavender P. | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 20,214 | 84,028 (0%) | 0% | 0 | Common Stock | |
| Fifth Third Bancorp | Robert Shaffer P. | EVP and Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 20,214 | 114,972 (0%) | 0% | 0 | Common Stock | |
| Deluxe Corp | Capers Garry L. | SVP, Chief of Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 20,050 | 20,050 | - | - | Restricted Stock Unit | |
| My Size Inc | Arik Kaufman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| My Size Inc | Oren Elmaliah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| My Size Inc | Zimmerman Guy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| My Size Inc | Branitzky Oron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| Super Micro Computer | Don Clegg | SVP, Worldwide Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.10 per share. | 14 Feb 2024 | 20,000 | 24,837 (0%) | 0% | 22.1 | 442,000 | Common Stock |
| Super Micro Computer | Clegg Don | SVP, Worldwide Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 20,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Uber | Hazelbaker Jill | See Remarks | Sale of securities on an exchange or to another person at price $ 77.83 per share. | 14 Feb 2024 | 20,000 | 107,290 (0%) | 0% | 77.8 | 1,556,674 | Common Stock |
| Tractor Supply | D. Robert Mills | EVP Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 232.48 per share. | 14 Feb 2024 | 19,870 | 29,527 (0%) | 0% | 232.5 | 4,619,378 | Common stock |
| Evercore Inc (Class A) | Roger Altman C. | Director, Founder and Senior Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 19,859 | 83,946 (0%) | 0% | 0 | Shares of Class A common stock, par value $0.01 per share | |
| Consolidated Edison | Ketschke Matthew | President, CECONY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 19,600 | 19,600 | - | - | Performance Units | |
| Citizens Financial Group | Brendan Coughlin | Head of Consumer Banking | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 19,540 | 104,761 (0%) | 0% | 0 | Common Stock | |
| Service Corp Intl | Elisabeth Nash G. | Sr. V.P. Operations Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 19,400 | 19,400 | - | - | Employee Stock Option (right to buy) | |
| Ventas | Carey Roberts S. | EVP and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 19,344 | 118,803 (0%) | 0% | 0 | Common Stock | |
| Fifth Third Bancorp | Bryan D. Preston | Chief Financial Officer & EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 19,310 | 19,310 | - | - | Stock Appreciation Rights | |
| Consolidated Edison | Matthew Ketschke | President, CECONY | Sale or transfer of securities back to the company at price $ 86.67 per share. | 14 Feb 2024 | 19,106 | 22,112 (0%) | 0% | 86.7 | 1,655,917 | Common Stock |
| Eastman Chemical | Costa J. Mark | Director, CEO & Board Chair | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.12 per share. | 14 Feb 2024 | 18,850 | 407,699 (0%) | 0% | 82.1 | 1,547,962 | Common Stock |
| ANI Pharma Inc | Christopher Mutz | HEAD OF RARE DISEASE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 18,790 | 82,397 (0%) | 0% | 0 | Common Stock | |
| Cooper-Standard Holdings Inc | Couch E. Christopher | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 18,703 | 18,703 | - | - | Restricted Stock Units | |
| Cooper-Standard Holdings Inc | Clark Patrick R. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 18,703 | 18,703 | - | - | Restricted Stock Units | |
| MACOM Tech Soln Holdings Inc | Ocampo Susan | Director, Ten Percent Owner | 14 Feb 2024 | 18,694 | 7,111,661 (10%) | 0% | 86.0 | 1,608,058 | Common Stock | |
| O'Reilly Automotive | D. Gregory Johnson | FORMER RETIRED CEO | Sale of securities on an exchange or to another person at price $ 1037.62 per share. | 14 Feb 2024 | 18,692 | 4,829 (0%) | 0% | 1037.6 | 19,395,255 | Common stock |
| Murphy USA Inc | R. Clyde Andrew | Director, President & CEO | 14 Feb 2024 | 18,500 | 35,600 | - | - | Performance Stock Unit | ||
| National Retail Properties Inc | Gina M. Steffens | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 39.72 per share. | 14 Feb 2024 | 18,481 | 32,441 (0%) | 0% | 39.7 | 734,065 | Common Stock |
| Nike | G. Parker Mark | Director, EXECUTIVE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2024 | 18,377 | 1,237,223 (0%) | 0% | 0 | Class B Common Stock | |
| C4 Therapeutics Inc | Mark Mossler | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 18,290 | 19,790 | - | 0 | Common Stock | |
| Eastgroup Properties Inc | A. Loeb Marshall | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 18,233 | 128,974 (0%) | 0% | 0 | Common Stock | |
| MACOM Tech Soln Holdings Inc | Susan Ocampo | Director, Ten Percent Owner | 14 Feb 2024 | 18,210 | 7,130,355 (10%) | 0% | 86.1 | 1,566,971 | Common Stock | |
| Ventas | Robert Probst F. | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.61 per share. | 14 Feb 2024 | 18,100 | 194,903 (0%) | 0% | 45.6 | 825,541 | Common Stock |
| Talphera Inc | Asadorian Raffi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 18,000 | 38,291 (0%) | 0% | 0 | Common Stock | |
| Talphera Inc | Pamela Palmer P. | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 18,000 | 53,344 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics | Doherty T. Catherine | SVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 17,939 | 17,939 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Meta | Zuckerberg Mark | Director, COB and CEO, Ten Percent Owner | 14 Feb 2024 | 17,925 | 3,787,841 | - | - | Class B Common Stock | ||
| Meta | Zuckerberg Mark | Director, COB and CEO, Ten Percent Owner | 14 Feb 2024 | 17,925 | 17,925 (0%) | 0% | 0 | Class A Common Stock | ||
| Live Oak Bancshares Inc | William C. Losch | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 17,923 | 71,692 | - | - | Restricted Stock Units | |
| Live Oak Bancshares Inc | William Losch C. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 17,923 | 79,069 (0%) | 0% | - | Voting Common Stock | |
| Live Oak Bancshares Inc | Derraik Renato | Chief Info./Digital Off., Bank | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 17,923 | 71,692 | - | - | Restricted Stock Units | |
| Live Oak Bancshares Inc | Renato Derraik | Chief Info./Digital Off., Bank | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 17,923 | 30,851 (0%) | 0% | - | Voting Common Stock | |
| Fifth Third Bancorp | Schramm Jude A. | EVP & CIO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 17,895 | 92,580 (0%) | 0% | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.